Anebulo Pharmaceuticals Stock Price on September 18, 2024
| ANEB Stock | USD 1.46 0.04 2.67% |
If you're considering investing in Anebulo Stock, it is important to understand the factors that can impact its price. As of today, the current price of Anebulo Pharmaceuticals stands at 1.46, as last reported on the 25th of November, with the highest price reaching 1.58 and the lowest price hitting 1.42 during the day. Anebulo Pharmaceuticals secures Sharpe Ratio (or Efficiency) of -0.0154, which signifies that the company had a -0.0154% return per unit of standard deviation over the last 3 months. Anebulo Pharmaceuticals exposes twenty-four different technical indicators, which can help you to evaluate volatility embedded in its price movement. Please confirm Anebulo Pharmaceuticals' mean deviation of 5.2, and Risk Adjusted Performance of 0.0058 to double-check the risk estimate we provide.
The current year's Common Stock Shares Outstanding is expected to grow to about 26.7 M, whereas Total Stockholder Equity is forecasted to decline to about 3.6 M. . At present, Anebulo Pharmaceuticals' Price Book Value Ratio is projected to increase significantly based on the last few years of reporting. The current year's Price Earnings To Growth Ratio is expected to grow to 0.28, whereas Price Earnings Ratio is forecasted to decline to (8.86). Anebulo Stock price history is provided at the adjusted basis, taking into account all of the recent filings.
Anebulo |
Sharpe Ratio = -0.0154
| Best Portfolio | Best Equity | |||
| Good Returns | ||||
| Average Returns | ||||
| Small Returns | ||||
| Cash | Small Risk | Average Risk | High Risk | Huge Risk |
| Negative Returns | ANEB |
Estimated Market Risk
| 9.01 actual daily | 80 80% of assets are less volatile |
Expected Return
| -0.14 actual daily | 0 Most of other assets have higher returns |
Risk-Adjusted Return
| -0.02 actual daily | 0 Most of other assets perform better |
Based on monthly moving average Anebulo Pharmaceuticals is not performing at its full potential. However, if added to a well diversified portfolio the total return can be enhanced and market risk can be reduced. You can increase risk-adjusted return of Anebulo Pharmaceuticals by adding Anebulo Pharmaceuticals to a well-diversified portfolio.
Price Book 19.9411 | Book Value 0.147 | Enterprise Value 36.5 M | Enterprise Value Ebitda (6.54) | Shares Float 3.9 M |
Related Headline
HCW Biologics Headline on 18th of September 2024
Acquisition by Greene Rick S. of 35714 shares of HCW Biologi... by MacroaxisInsider
Filed transaction by HCW Biologics Director. Grant, award or other acquisition pursuant to Rule 16b-3
Anebulo Pharmaceuticals Valuation on September 18, 2024
It is possible to determine the worth of Anebulo Pharmaceuticals on a given historical date. On September 18, 2024 Anebulo was worth 2.14 at the beginning of the trading date compared to the closed value of 2.0. We use multiple weighted factors in our valuation methodologies to arrive at the intrinsic value of Anebulo Pharmaceuticals stock. Still, in general, we apply an absolute valuation method to find Anebulo Pharmaceuticals' value based on its fundamental and technical indicators available within our service. As compared to an absolute model, our relative valuation model uses a comparative analysis of Anebulo Pharmaceuticals where we calculate exposure to its market risk and evaluate relevant financial multiples and ratios against Anebulo Pharmaceuticals' related companies.
| Open | High | Low | Close | Volume | |
| 2.01 | 2.30 | 2.01 | 2.27 | 5,219 | |
09/18/2024 | 2.14 | 2.32 | 2.00 | 2.00 | 5,765 |
| 2.08 | 2.08 | 2.08 | 2.08 | 585.00 |
| Backtest Anebulo Pharmaceuticals | | | Anebulo Pharmaceuticals History | | | Anebulo Pharmaceuticals Valuation | Previous | Next |
Anebulo Pharmaceuticals Trading Date Momentum on September 18, 2024
| On September 19 2024 Anebulo Pharmaceuticals was traded for 2.08 at the closing time. The top price for the day was 2.08 and the lowest listed price was 2.08 . The trading volume for the day was 585. The trading history from September 19, 2024 was a factor to the next trading day price jump. The overall trading delta against the next closing price was 4.00% . The overall trading delta against the current closing price is 5.50% . |
Anebulo Pharmaceuticals Fundamentals Correlations and Trends
By evaluating Anebulo Pharmaceuticals' financials over time, investors can gain insight into future company performance. However, you can also analyze the published financial statements to find patterns among Anebulo Pharmaceuticals' main balance sheet or income statement drivers and many other relevant indicators that can statistically be found significantly correlated or uncorrelated. Anebulo financial account trend analysis is a perfect complement when working with valuation or volatility modules.About Anebulo Pharmaceuticals Stock history
Anebulo Pharmaceuticals investors dedicate a lot of time and effort to gaining insight into how a market's past behavior relates to its future. Access to timely market data for Anebulo is vital when making an investment decision, and regardless of whether you use fundamental or technical analysis, your return on investment in Anebulo Pharmaceuticals will depend on recognizing future opportunities and eliminating past mistakes. Historical data analysis is the study of market behavior over a given time. Recorded market-related data such as price, volatility, and volume can be quantified and studied over a defined period. Through a detailed examination of a market's past behavior, traders and investors can gain perspective on the inner workings of that market. The information obtained throughout analyzing Anebulo Pharmaceuticals stock prices may prove useful in developing a viable investing in Anebulo Pharmaceuticals
| Last Reported | Projected for Next Year | ||
| Common Stock Shares Outstanding | 25.8 M | 26.7 M | |
| Net Loss | -10.6 M | -10 M |
Anebulo Pharmaceuticals Quarterly Net Working Capital |
|
Anebulo Pharmaceuticals Stock Technical Analysis
Anebulo Pharmaceuticals technical stock analysis exercises models and trading practices based on price and volume transformations, such as the moving averages, relative strength index, regressions, price and return correlations, business cycles, stock market cycles, or different charting patterns.
Price Boundaries
Anebulo Pharmaceuticals Period Price Range
Low | November 25, 2024
| High |
0.00 | 0.00 |
Anebulo Pharmaceuticals cannot be verified against its exchange. Please verify the symbol is currently traded on NASDAQ Exchange. If you still believe the symbol you are trying to look up is valid, please let us know, and we will check it as soon as possible.
Anebulo Pharmaceuticals November 25, 2024 Market Strength
Market strength indicators help investors to evaluate how Anebulo Pharmaceuticals stock reacts to ongoing and evolving market conditions. The investors can use it to make informed decisions about market timing, and determine when trading Anebulo Pharmaceuticals shares will generate the highest return on investment. By undertsting and applying Anebulo Pharmaceuticals stock market strength indicators, traders can identify Anebulo Pharmaceuticals entry and exit signals to maximize returns
Anebulo Pharmaceuticals Technical and Predictive Indicators
Predictive indicators are helping investors to find signals for Anebulo Pharmaceuticals' price direction in advance. Along with the technical and fundamental analysis of Anebulo Stock historical price patterns, it is also worthwhile for investors to track various predictive indicators of Anebulo to make sure they correctly time the market and exploit it's hidden potentials. Even though most predictive indicators are useful for the short-term horizon, it's virtually impossible to predict the unforeseen market. For traders with a short-term horizon, predictive indicators add value when properly applied. Long-term investors, however, may find many predictive indicators less useful.
| Risk Adjusted Performance | 0.0058 | |||
| Jensen Alpha | (0.27) | |||
| Total Risk Alpha | (1.47) | |||
| Treynor Ratio | (0.03) |
| Cycle Indicators | ||
| Math Operators | ||
| Math Transform | ||
| Momentum Indicators | ||
| Overlap Studies | ||
| Pattern Recognition | ||
| Price Transform | ||
| Statistic Functions | ||
| Volatility Indicators | ||
| Volume Indicators |
Complementary Tools for Anebulo Stock analysis
When running Anebulo Pharmaceuticals' price analysis, check to measure Anebulo Pharmaceuticals' market volatility, profitability, liquidity, solvency, efficiency, growth potential, financial leverage, and other vital indicators. We have many different tools that can be utilized to determine how healthy Anebulo Pharmaceuticals is operating at the current time. Most of Anebulo Pharmaceuticals' value examination focuses on studying past and present price action to predict the probability of Anebulo Pharmaceuticals' future price movements. You can analyze the entity against its peers and the financial market as a whole to determine factors that move Anebulo Pharmaceuticals' price. Additionally, you may evaluate how the addition of Anebulo Pharmaceuticals to your portfolios can decrease your overall portfolio volatility.
| Instant Ratings Determine any equity ratings based on digital recommendations. Macroaxis instant equity ratings are based on combination of fundamental analysis and risk-adjusted market performance | |
| Idea Optimizer Use advanced portfolio builder with pre-computed micro ideas to build optimal portfolio | |
| Price Ceiling Movement Calculate and plot Price Ceiling Movement for different equity instruments | |
| Correlation Analysis Reduce portfolio risk simply by holding instruments which are not perfectly correlated | |
| Idea Breakdown Analyze constituents of all Macroaxis ideas. Macroaxis investment ideas are predefined, sector-focused investing themes | |
| AI Portfolio Architect Use AI to generate optimal portfolios and find profitable investment opportunities | |
| Positions Ratings Determine portfolio positions ratings based on digital equity recommendations. Macroaxis instant position ratings are based on combination of fundamental analysis and risk-adjusted market performance | |
| Premium Stories Follow Macroaxis premium stories from verified contributors across different equity types, categories and coverage scope |